Cargando…
Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis
YAP1 is a transcriptional coactivator and the principal effector of the Hippo signaling pathway, which is causally implicated in human cancer. Several YAP1 gene fusions have been identified in various human cancers and identifying the essential components of this family of gene fusions has significa...
Autores principales: | Szulzewsky, Frank, Arora, Sonali, Hoellerbauer, Pia, King, Claire, Nathan, Erica, Chan, Marina, Cimino, Patrick J., Ozawa, Tatsuya, Kawauchi, Daisuke, Pajtler, Kristian W., Gilbertson, Richard J., Paddison, Patrick J., Vasioukhin, Valeri, Gujral, Taranjit S., Holland, Eric C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397849/ https://www.ncbi.nlm.nih.gov/pubmed/32675324 http://dx.doi.org/10.1101/gad.338681.120 |
Ejemplares similares
-
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice
por: Szulzewsky, Frank, et al.
Publicado: (2022) -
A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways
por: Pattwell, Siobhan S., et al.
Publicado: (2020) -
A simple and highly efficient method for multi‐allelic CRISPR‐Cas9 editing in primary cell cultures
por: Hoellerbauer, Pia, et al.
Publicado: (2020) -
Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers
por: Arakaki, Aleena K S, et al.
Publicado: (2021) -
Phenotypic characterization with somatic genome editing and gene transfer reveals the diverse oncogenicity of ependymoma fusion genes
por: Takadera, Mutsumi, et al.
Publicado: (2020)